Multiparametric Magnetic Resonance Imaging, Spectroscopy and Multinuclear (23Na) Imaging Monitoring of Preoperative Chemotherapy for Locally Advanced Breast Cancer

Academic Radiology

Volumn 17, Issue 12, 2010, Pages 1477-1485

  Jacobs, Michael A ^a,b   Stearns, Vered ^b   Wolff, Antonio C ^b   Macura, Katarzyna ^a   Argani, Pedram ^a,b   Khouri, Nagi ^a   Tsangaris, Theodore ^b   Barker, Peter B ^a   Davidson, Nancy E ^b   Bhujwalla, Zaver M ^a,b   Bluemke, David A ^a,c   Ouwerkerk, Ronald ^a,d  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c CLINICAL CENTER   (United States)

^d NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

23Na; Advanced cancer; Breast; Magnetic resonance imaging; Proton; Sodium MR; Spectroscopy

Indexed keywords

CYCLOPHOSPHAMIDE; DOCETAXEL; DOXORUBICIN; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; PACLITAXEL; SODIUM 23; TRASTUZUMAB; TUMOR MARKER;

ADULT; ADVANCED CANCER; AGED; ARTICLE; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER SIZE; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; FEMALE; HUMAN; HUMAN TISSUE; MULTINUCLEAR IMAGING; MULTIPLE CYCLE TREATMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PATHOLOGY; PHENOTYPE; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RECEIVER OPERATING CHARACTERISTIC; SIGNAL NOISE RATIO; TREATMENT RESPONSE; TUMOR VOLUME;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST NEOPLASMS; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MIDDLE AGED; NEOPLASM STAGING; PROSPECTIVE STUDIES; SODIUM;

EID: 78149411947     PISSN: 10766332     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.acra.2010.07.009     Document Type: Article

References (51)

1. Jemal A., Siegel R., Ward E., et al. Cancer statistics, 2009. CA Cancer J Clin 2009, 59:225-249.
2. Lehman C.D., Gatsonis C., Kuhl C.K., et al. MRI evaluation of the contralateral breast in women with recently diagnosed breast cancer. N Engl J Med 2007, 356:1295-1303.
3. El Khouli R.H., Jacobs M.A., Bluemke D.A. Magnetic resonance imaging of the breast. Semin Roentgenol 2008, 43:265-281.
4. Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet 2005, 365:1687-1717. Early Breast Cancer Trialists' Collaborative Group.
5. Wolff A.C., Berry D., Carey L.A., et al. Research issues affecting preoperative systemic therapy for operable breast cancer. J Clin Oncol 2008, 26:806-813.
6. Fisher B., Redmond C., Brown A., et al. Adjuvant chemotherapy with and without tamoxifen in the treatment of primary breast cancer: 5-year results from the National Surgical Adjuvant Breast and Bowel Project Trial. J Clin Oncol 1986, 4:459-471.
7. Fisher B., Redmond C., Wickerham D.L., et al. Systemic therapy in patients with node-negative breast cancer. A commentary based on two National Surgical Adjuvant Breast and Bowel Project (NSABP) clinical trials. Ann Intern Med 1989, 111:703-712.
8. Kaufmann M., Hortobagyi G.N., Goldhirsch A., et al. Recommendations from an international expert panel on the use of neoadjuvant (primary) systemic treatment of operable breast cancer: an update. J Clin Oncol 2006, 24:1940-1949.
9. Fisher B., Bryant J., Wolmark N., et al. Effect of preoperative chemotherapy on the outcome of women with operable breast cancer. J Clin Oncol 1998, 16:2672-2685.
10. The effect on primary tumor response of adding sequential Taxotere to Adriamycin and cyclophosphamide: preliminary results from NSABP protocol B-27. Breast Cancer Res Treat 2001, 69:215. National Surgical Adjuvant Breast and Bowel Project.
11. Esserman L., Hylton N., Yassa L., et al. Utility of magnetic resonance imaging in the management of breast cancer: evidence for improved preoperative staging. J Clin Oncol 1999, 17:110-119.
12. Partridge S.C., Gibbs J.E., Lu Y., et al. MRI measurements of breast tumor volume predict response to neoadjuvant chemotherapy and recurrence-free survival. AJR Am J Roentgenol 2005, 184:1774-1781.
13. Yu H.J., Chen J.H., Mehta R.S., et al. MRI measurements of tumor size and pharmacokinetic parameters as early predictors of response in breast cancer patients undergoing neoadjuvant anthracycline chemotherapy. J Magn Reson Imaging 2007, 26:615-623.
14. Meisamy S., Bolan P.J., Baker E.H., et al. Neoadjuvant chemotherapy of locally advanced breast cancer: predicting response with in vivo 1H MR spectroscopy-a pilot study at 4 T. Radiology 2004, 233:424-431.
15. Manton D.J., Chaturvedi A., Hubbard A., et al. Neoadjuvant chemotherapy in breast cancer: early response prediction with quantitative MR imaging and spectroscopy. Br J Cancer 2006, 94:427-435.
16. Kumar V., Jagannathan N.R., Kumar R., et al. Correlation between metabolite ratios and ADC values of prostate in men with increased PSA level. Magn Reson Imaging 2006, 24:541-548.
17. Baek H.M., Chen J.H., Nie K., et al. Predicting pathologic response to neoadjuvant chemotherapy in breast cancer by using MR imaging and quantitative 1H MR spectroscopy. Radiology 2009, 251:653-662.
18. Jacobs M.A., Ouwerkerk R., Wolff A.C., et al. Multiparametric and multinuclear magnetic resonance imaging of human breast cancer: current applications. Technol Cancer Res Treat 2004, 3:543-550.
19. Ouwerkerk R., Jacobs M.A., Macura K.J., et al. Elevated tissue sodium concentration in malignant breast lesions detected with non-invasive (23)Na MRI. Breast Cancer Res Treat 2007, 106:151-160.
20. Jacobs M.A., Ouwerkerk R., Kamel I., et al. Proton, diffusion-weighted imaging, and sodium ((23)Na) MRI of uterine leiomyomata after MR-guided high-intensity focused ultrasound: a preliminary study. J Magn Reson Imaging 2009, 29:649-656.
21. Bottomley P.A. Spatial localization in NMR spectroscopy in vivo. Ann N Y Acad Sci 1987, 508:333-348.
22. Jacobs M.A., Barker P.B., Bluemke D.A., et al. Benign and malignant breast lesions: diagnosis with multiparametric MR imaging. Radiology 2003, 229:225-232.
23. Haase A., Frahm J., Hanicke W., et al. H-1-NMR chemical-shift selective (CHESS) imaging. Phys Med Biol 1985, 30:341-344.
24. Therasse P., Eisenhauer E.A., Verweij J. RECIST revisited: a review of validation studies on tumour assessment. Eur J Cancer 2006, 42:1031-1039.
25. Eisenhauer E.A., Therasse P., Bogaerts J., et al. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer 2009, 45:228.
26. Jacobs M.A., Knight R.A., Windham J.P., et al. Identification of cerebral ischemic lesions in rat using eigenimage filtered magnetic resonance imaging. Brain Res 1999, 837:83-94.
27. Jacobs M.A., Barker P.B., Bottomley P.A., et al. Proton MR spectroscopic imaging of human breast cancer: a preliminary study. J Magn Reson Imaging 2004, 19:68-75.
28. Baek H.M., Yu H.J., Chen J.H., et al. Quantitative correlation between (1)H MRS and dynamic contrast-enhanced MRI of human breast cancer. Magn Reson Imaging 2008, 26:523-531.
29. Ouwerkerk R., Bleich K.B., Gillen J.S., et al. Tissue sodium concentration in human brain tumors as measured with 23Na MR imaging. Radiology 2003, 227:529-537.
30. Ouwerkerk R., Weiss R.G., Bottomley P.A. Measuring human cardiac tissue sodium concentrations using surface coils, adiabatic excitation, and twisted projection imaging with minimal T2 losses. J Magn Reson Imaging 2005, 21:546-555.
31. Hilal S.K., Maudsley A.A., Ra J.B., et al. In vivo NMR imaging of sodium-23 in the human head. J Comput Assist Tomogr 1985, 9:1-7.
32. Nagy I., Lustyik G., Lukacs G., et al. Correlation of malignancy with the intracellular Na+:K+ ratio in human thyroid tumors. Cancer Res 1983, 43:5395-5402.
33. Navon G. Complete elimination of the extracellular 23Na NMR signal in triple quantum filtered spectra of rat hearts in the presence of shift reagents. Magn Reson Med 1993, 30:503-506.
34. Kline R.P., Wu E.X., Petrylak D.P., et al. Rapid in vivo monitoring of chemotherapeutic response using weighted sodium magnetic resonance imaging. Clin Cancer Res 2000, 6:2146-2156.
35. Winter P.M., Poptani H., Bansal N. Effects of chemotherapy by 1,3-bis(2-chloroethyl)-1-nitrosourea on single-quantum- and triple-quantum-filtered 23Na and 31P nuclear magnetic resonance of the subcutaneously implanted 9L glioma. Cancer Res 2001, 61:2002-2007.
36. Babsky A.M., Topper S., Zhang H., et al. Evaluation of extra- and intracellular apparent diffusion coefficient of sodium in rat skeletal muscle: effects of prolonged ischemia. Magn Reson Med 2008, 59:485-491.
37. Pike M.M., Frazer J.C., Dedrick D.F., et al. 23Na and 39K nuclear magnetic resonance studies of perfused rat hearts. Discrimination of intra- and extracellular ions using a shift reagent. Biophys J 1985, 48:159-173.
38. Pekar J., Renshaw P.F., Leigh J.S. Selective detection of intracellular sodium by coherence-transfer NMR. J Magn Reson 1987, 72:159-161.
39. Winter P.M., Bansal N. Triple-quantum-filtered 23Na NMR spectroscopy of subcutaneously implanted 9L gliosarcoma in the rat in the presence of TmDOTP5-J Magn Reson 2001, 152:70-78.
40. Tanase C., Boada F.E. Triple-quantum-filtered imaging of sodium in presence of B(0) inhomogeneities. J Magn Reson 2005, 174:270-278.
41. Glunde K., Jacobs M.A., Pathak A.P., et al. Molecular and functional imaging of breast cancer. NMR Biomed 2009, 22:92-103.
42. Glunde K., Jacobs M.A., Bhujwalla Z.M. Choline metabolism in cancer: implications for diagnosis and therapy. Expert Rev Mol Diagn 2006, 6:821-829.
43. Negendank W., Li C.W., Padavic-Shaller K., et al. Phospholipid metabolites in 1H-decoupled 31P MRS in vivo in human cancer: implications for experimental models and clinical studies. Anticancer Res 1996, 16:1539-1544.
44. Soher B.J., van Zijl P.C., Duyn J.H., et al. Quantitative proton MR spectroscopic imaging of the human brain. Magn Reson Med 1996, 35:356-363.
45. Bolan P.J., Meisamy S., Baker E.H., et al. In vivo quantification of choline compounds in the breast with 1H MR spectroscopy. Magn Reson Med 2003, 50:1134-1143.
46. Baik H.M., Su M.Y., Yu H., et al. Quantification of choline-containing compounds in malignant breast tumors by 1H MR spectroscopy using water as an internal reference at 1.5 T. Magma 2006, 19:96-104.
47. Fayad L.M., Salibi N., Wang X., et al. Quantification of muscle choline concentrations by proton MR spectroscopy at 3 T: technical feasibility. AJR Am J Roentgenol 2010, 194:W73-W79.
48. Woodhams R., Matsunaga K., Iwabuchi K., et al. Diffusion-weighted imaging of malignant breast tumors: the usefulness of apparent diffusion coefficient (ADC) value and ADC map for the detection of malignant breast tumors and evaluation of cancer extension. J Comput Assist Tomogr 2005, 29:644-649.
49. El Khouli R.H., Macura K.J., Barker P.B., et al. Relationship of temporal resolution to diagnostic performance for dynamic contrast enhanced MRI of the breast. J Magn Reson Imaging 2009, 30:999-1004.
50. Jin G., An N., Jacobs M.A., Li K. The role of parallel diffusion-weighted imaging and apparent diffusion coefficient (ADC) map values for evaluating breast lesions: preliminary results. Acad Radiol 2010, 17:456-463.
51. El Khouli R.H., Jacobs M.A., Macura K.J., et al. Diffusion weighted imaging improves the diagnostic accuracy of conventional breast MRI at 3 tesla. Radiology 2010, 256:64-73.